IONIS PHARMACEUTICALS INC Uncategorized Contracts & Agreements
46 Contracts & Agreements
- Form of Indemnity Agreement entered into between the Registrant and its Directors and Executive Officers with related schedule (Filed With SEC on February 21, 2024)
- Description of the Registrants Securities (Filed With SEC on February 25, 2022)
- [Signature page to follow] (Filed With SEC on May 5, 2021)
- Letter Agreement between the Registrant, Akcea Therapeutics, Inc., and Pfizer Inc., dated October 4, 2019. Portions of this exhibit have been omitted because they are both (i) not... (Filed With SEC on March 2, 2020)
- Description of the Registrants Securities (Filed With SEC on March 2, 2020)
- Amendment No. 1 to the Neurology III Agreement between the Registrant and Biogen MA Inc., dated August 16, 2019 (portions of the exhibit have been omitted because they are both... (Filed With SEC on November 6, 2019)
- IONIS PHARMACEUTICALS, INC. EMPLOYEE CONFIDENTIAL INFORMATION AND INVENTIONS AGREEMENT (Filed With SEC on February 28, 2018)
- ISIS PHARMACEUTICALS, INC. (Filed With SEC on February 28, 2018)
- 225 Binney Street, Cambridge, MA 02142 " Phone ###-###-#### " www.biogen.com (Filed With SEC on March 1, 2017)
- AMENDMENT NO.3 (Filed With SEC on May 5, 2016)
- CONFIDENTIAL TREATMENT REQUESTEDUNDER 17 C.F.R 200.80(B)4, AND 240.24B-2 Exhibit 10.1ConfidentialExecution CopyLicense Agreement Between Isis Pharmaceuticals, Inc., And Bayer... (Filed With SEC on August 5, 2015)
- AMENDMENT NO.2 (Filed With SEC on March 2, 2015)
- [Signature page follows] (Filed With SEC on March 2, 2015)
- Letter Agreement Amendment between the Registrant and Biogen Idec International Holding Ltd dated January 27, 2014. Portions of this exhibit have been omitted and separately filed... (Filed With SEC on May 6, 2014)
- INDEMNITY AGREEMENT (Filed With SEC on February 28, 2013)
- Isis Pharmaceuticals, Inc. Requests that the marked portions of the exhibit be granted confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934. (Filed With SEC on November 6, 2012)
- RESEARCH AGREEMENT (Filed With SEC on November 8, 2011)
- NON-EXCLUSIVE TECHNOLOGY ALLIANCE AND OPTION AGREEMENT between REGULUS THERAPEUTICS INC. and SANOFI-AVENTIS (Filed With SEC on August 9, 2010)
- ARTICLE36 OPTIONTO EXTEND (Filed With SEC on May 7, 2010)
- LEASEAGREEMENT (Filed With SEC on May 7, 2010)
- EXCLUSIVE LICENSEAND NONEXCLUSIVE OPTION AGREEMENT BETWEEN GLAXO GROUPLIMITED AND REGULUSTHERAPEUTICS INC. (Filed With SEC on May 7, 2010)
- AMENDMENT #1 TO THE PRODUCTDEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on May 7, 2010)
- C O N F I D E N T I A L PRE-CLINICAL DEVELOPMENTCOLLABORATION AGREEMENT (Filed With SEC on February 26, 2009)
- Isis Policy andProcedures Manual (Filed With SEC on December 5, 2008)
- EXHIBIT A SEPARATIONAGREEMENT (Filed With SEC on December 5, 2008)
- EXHIBIT A SEPARATIONAGREEMENT (Filed With SEC on December 5, 2008)
- CALL OPTION AGREEMENT BY AND AMONG ISIS PHARMACEUTICALS, INC., IBIS BIOSCIENCES, INC. AND ABBOTT MOLECULAR INC. January 30, 2008 (Filed With SEC on May 12, 2008)
- STRATEGICALLIANCE MASTER AGREEMENT AMONG IBISBIOSCIENCES, INC. ISISPHARMACEUTICALS, INC. AND ABBOTTMOLECULAR INC. January 30, 2008 (Filed With SEC on May 12, 2008)
- CONFIDENTIAL TREATMENTREQUESTED UNDER 17 C.F.R 200.80(b)4,AND 240.24b-2 (Filed With SEC on May 12, 2008)
- AMENDMENT NO. 1 TO SALE AGREEMENT (Filed With SEC on October 17, 2007)
- AMENDMENT NO. 1 (Filed With SEC on August 9, 2007)
- LICENSEAGREEMENT (Filed With SEC on May 10, 2007)
- REGISTRATION RIGHTSAGREEMENT BY AND BETWEEN ISIS PHARMACEUTICALS,INC., AS ISSUER AND LEHMAN BROTHERS INC., ASREPRESENTATIVE OF THE INITIAL PURCHASERS DATED AS OF JANUARY 23,2007 (Filed With SEC on January 24, 2007)
- ISISPHARMACEUTICALS, INC. (Filed With SEC on January 24, 2007)
- CONFIDENTIAL TREATMENTREQUESTED UNDER 17 C.F.R. 200.80(b)4, AND 240.24b-2 (Filed With SEC on May 10, 2006)
- CONFIDENTIAL TREATMENTREQUESTED UNDER 17 C.F.R. 200.80(b)4, AND 240.24b-2 (Filed With SEC on May 10, 2006)
- CONFIDENTIAL TREATMENTREQUESTED UNDER 17 C.F.R. 200.80(b)4, AND 240.24b-2 (Filed With SEC on May 10, 2006)
- CONFIDENTIALTREATMENT REQUESTED UNDER 17 C.F.R. 200.80(b)4, AND 240.24b-2 (Filed With SEC on May 10, 2006)
- SUBCONTRACT AGREEMENT Time and Material /Labor Hour (Filed With SEC on November 9, 2005)
- NOTICE OF GRANT AWARD (Filed With SEC on November 9, 2005)
